Area of research
Pulmonary and Respiratory Medicine · Public Health, Environmental and Occupational Health
Research interest
Research interests include Medicine, Pediatrics, Fluconazole, Retinopathy of prematurity, Pharmacokinetics, and Dosing.
Early-Life Factors and Body Mass Index Trajectories Among Children in the ECHO Cohort
Neighborhood Food Access in Early Life and Trajectories of Child Body Mass Index and Obesity
Green Space and Internalizing or Externalizing Symptoms Among Children
Influence of Eat, Sleep, and Console on Infants Pharmacologically Treated for Opioid Withdrawal
Association of Growth During Infancy with Neurodevelopment and Obesity in Children Born Very Preterm: The Environmental Influences on Child Health Outcomes Cohort
Abatacept, Cenicriviroc, or Infliximab for Treatment of Adults Hospitalized With COVID-19 Pneumonia
Analysis of Pregnancy Complications and Epigenetic Gestational Age of Newborns
Evaluation of pediatric epigenetic clocks across multiple tissues
Prenatal Exposure to Nonpersistent Environmental Chemicals and Postpartum Depression
Neurodevelopmental and behavioral outcomes of very preterm infants: latent profile analysis in the Environmental influences on Child Health Outcomes (ECHO) Program
Disparities in Risks of Inadequate and Excessive Intake of Micronutrients during Pregnancy
Distributional Properties and Criterion Validity of a Shortened Version of the Social Responsiveness Scale: Results from the ECHO Program and Implications for Social Communication Research
Inadequate oral feeding as a barrier to discharge in moderately preterm infants
Gastrostomy Tube Feeding in Extremely Low Birthweight Infants: Frequency, Associated Comorbidities, and Long-term Outcomes
Physiologically‐Based Pharmacokinetic Modeling of Fluconazole Using Plasma and Cerebrospinal Fluid Samples From Preterm and Term Infants
Population pharmacokinetics of sildenafil in extremely premature infants
Survival and Neurodevelopmental Outcomes among Periviable Infants
External Evaluation of Two Fluconazole Infant Population Pharmacokinetic Models
Between-Hospital Variation in Treatment and Outcomes in Extremely Preterm Infants
Feasibility of Autologous Cord Blood Cells for Infants with Hypoxic-Ischemic Encephalopathy
Trends in Caffeine Use and Association between Clinical Outcomes and Timing of Therapy in Very Low Birth Weight Infants
Effect of Fluconazole Prophylaxis on Candidiasis and Mortality in Premature Infants
Developmental Pharmacokinetics of Piperacillin and Tazobactam Using Plasma and Dried Blood Spots from Infants
Medication Use in the Neonatal Intensive Care Unit
Catheter Dwell Time and CLABSIs in Neonates With PICCs: A Multicenter Cohort Study
Individual and Center-Level Factors Affecting Mortality Among Extremely Low Birth Weight Infants
Toll-like Receptor 1 Polymorphisms Increase Susceptibility to Candidemia
Approach to Infants Born at 22 to 24 Weeks’ Gestation: Relationship to Outcomes of More-Mature Infants
Safety and Effectiveness of Meropenem in Infants With Suspected or Complicated Intra-abdominal Infections
Empiric Antifungal Therapy and Outcomes in Extremely Low Birth Weight Infants with Invasive Candidiasis